15 completed, 2 unknown, 1 recruiting. 18 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 18 | Completed 15, Unknown 2, Recruiting 1 |
| Phase 2 | 5 | Completed 4, Unknown 1 |
Follow Olive Oil: new trials by email Literature Review of Olive Oil trials Research Report on Olive Oil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma Cholecalciferol D3, Olive oil - Asthma, Respiratory Tract Infections | Phase 3 | Recruiting | Professor Klaus Bønnelykke | 2000 | 2024-12-20 | 2025-09-30 |
| Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial Turmeric Extract, Turmeric Extract in Olive oil, Petrolatum - Psoriasis | Phase 2 / Phase 3 | Unknown | Zagazig University | 50 | 2019-09-01 | 2019-08-28 |
| High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial placebo Oil, 25-Hydroxyvitamin D - HIV-1-infection, Hypovitaminosis D | Phase 3 | Completed | University of the Punjab | 95 | 2019-02-15 | 2022-04-11 |
| The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation Omacor, Placebo Oral Capsule - Kidney Transplantation | Phase 3 | Completed | Joe Chan | 174 | 2017-09-01 | 2025-04-03 |
| Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix AV2, Placebo - Uterine Cervical Dysplasia, Papillomavirus Infections | Phase 3 | Completed | Jean-Pierre Van geertruyden | 327 | 2015-01-01 | 2018-10-12 |
| The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO) Omega-3 polyunsaturated fatty acids, Olive oil - Pregnancy, Depression | Phase 3 | Completed | Tokyo Medical University | 108 | 2014-06-01 | 2017-12-21 |
| Epanova® for Lowering Very High Triglycerides II (EVOLVE II) Epanova, Olive Oil - Hypertriglyceridemia | Phase 3 | Completed | AstraZeneca | 379 | 2013-12-16 | 2019-09-10 |
| Effect of Omega-3 Fatty Acid on Endothelial Function Omega-3, placebo - Familial Hypercholesterolemia | Phase 3 | Completed | Nordlandssykehuset HF | 34 | 2013-03-01 | 2019-05-13 |
| Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients omega 3 fatty acids, placebo - HIV/AIDS | Phase 3 | Completed | Coordinación de Investigación en Salud, Mexico | 70 | 2013-01-01 | 2015-08-18 |
| Antiperistaltic Effect and Safety of L-menthol in the Elderly With Contraindication to Buscopan L-menthol, Placebo - Upper Gastrointestinal Endoscopy | Phase 3 | Unknown | Taipei Veterans General Hospital, Taiwan | 60 | 2012-03-01 | 2020-10-20 |
| [E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL Olive oil, 4g, omega-3-carboxylic acids, 2g, omega-3-carboxylic acids, 4g - Hypertriglyceridemia, Cardiovascular Disease | Phase 3 | Completed | AstraZeneca | 646 | 2011-08-01 | 2014-12-05 |
| An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients Omacor®, Placebo - Hypertriglyceridemia | Phase 3 | Completed | Excelsior | 253 | 2011-07-01 | 2014-05-19 |
| Effect of Calanus Oli on Intra-abdominal Fat, Glucose Tolerance and Lipids in Man calanus oil, olive oil - Overweight | Phase 2 / Phase 3 | Completed | University of Tromso | 117 | 2010-12-01 | 2012-09-05 |
| Dry Eye Assessment and Management: Feasibility Study Omega-3 EFA Supplement, Olive Oil - Dry Eye Syndromes, Keratoconjunctivitis Sicca | Phase 2 / Phase 3 | Completed | Asbell, Penny, M.D. | 23 | 2010-01-01 | 2012-08-23 |
| Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails Indigo Naturalis Extract in Oil, Olive Oil - Nail Psoriasis | Phase 2 / Phase 3 | Completed | Chang Gung Memorial Hospital | 31 | 2009-09-01 | 2019-08-07 |
| Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia Omega-3 Fatty Acids, Olive oil placebo, EPA fish oil concentrate; DHA fish oil concentrate - Schizophrenia, Fatty Acid Deficiency | Phase 2 / Phase 3 | Completed | University of Cincinnati | 2008-01-01 | 2011-08-02 | |
| Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents Omega 3/6 fatty acids, Placebo (olive oil) - ADHD, Reading/Writing Disorder | Phase 3 | Completed | Göteborg University | 82 | 2004-08-01 | 2010-10-13 |
| OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction Zodin (drug), Olive oil (placebo) - Myocardial Infarction | Phase 3 | Completed | Stiftung Institut fuer Herzinfarktforschung | 3800 | 2003-10-01 | 2008-09-12 |
Hypertriglyceridemia (3) · Dyslipidemias (2) · Infections (2) · Acquired Immunodeficiency Syndrome (1) · Asthma (1) · Attention Deficit Disorder with Hyperactivity (1) · Cardiovascular Diseases (1) · Croup (1) · Depression (1) · Dry Eye Syndromes (1) · Eczema (1) · Fractures, Bone (1) · Hyperlipidemias (1) · Hyperlipoproteinemia Type II (1) · Hypersensitivity (1)
AstraZeneca (2) · Asbell, Penny, M.D. (1) · Chang Gung Memorial Hospital (1) · Coordinación de Investigación en Salud, Mexico (1) · Excelsior (1) · Göteborg University (1) · Jean-Pierre Van geertruyden (1) · Joe Chan (1) · Nordlandssykehuset HF (1) · Professor Klaus Bønnelykke (1) · Stiftung Institut fuer Herzinfarktforschung (1) · Taipei Veterans General Hospital, Taiwan (1) · Tokyo Medical University (1) · University of Cincinnati (1) · University of Tromso (1)
United States (4) · Norway (3) · Taiwan (3) · Denmark (2) · Canada (1) · Czechia (1) · Democratic Republic of the Congo (1) · Germany (1) · Hungary (1) · Japan (1) · Mexico (1) · Netherlands (1) · Pakistan (1) · Russia (1)
Alex Mutombo Baleka, MD (1) · Bo Chawes, PhD (1) · Branimir Draganov, MD (1) · Chuen-Den Tseng, M.D., PhD. (1) · Daisuke Nishi, M.D., Ph.D. (1) · Hagar Nofal (1) · Ivar Anders Eide, MD, PhD (1) · Jochen Senges, Prof. Dr. (1) · Joe Chan, MD (1) · Kuan-Pin Su, M.D., Ph.D. (1) · Mats Johnson, MD (1) · Michael H Davidson, MD, FACC (1)
PMID 21060071, PMID 22753087, PMID 23559535, PMID 23998969, PMID 24330904, PMID 26328624, PMID 27015634, PMID 27630014, PMID 29696202, PMID 31193477, PMID 35729250, PMID 36999528, PMID 39740942
2016 (1), R34EY017626 (1)